Micro Therapeutics Gets OK to Market 2 Catheters
- Share via
Micro Therapeutics Inc., which makes devices to treat vascular diseases, said Wednesday that it has obtained approval from the Food and Drug Administration to market two micro catheters.
The Irvine medical device company said in a press release that the two catheters, both in its Rebar product line, have a small-diameter model for neurosurgery applications and a slightly larger diameter model for peripheral vascular use.
The catheters also will be a standard component of a brain aneurysm treatment that Micro Therapeutics has in feasibility trials.
The company’s stock closed Wednesday at $10.50 a share, up 53 cents, in Nasdaq trading.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
